leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 22:40:52 - browse：18

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Rock icon Freddie Mercury pre

hotspot

WSS

Hospitals consider fixing cancer drug shortages on their own

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

How medical schools plan to diversify without affirmative action

Telehealth for opioid use disorder is lifesaving

Climate activists disrupt London Pride march to protest corporate sponsorship

Long Covid needs a new name — and a new frame

Wikipedia

leisure time

focus

ChatGPT in medicine: STAT answers readers' burning questions

Parkland mass shooting to be reenacted for lawsuit

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

Duchenne breakthrough therapy leaves behind pioneering families

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

As demand for Covid shots wanes, Moderna seeks its next success

Medical schools are missing the mark on artificial intelligence

New air purifier tech could be key to improving indoor air quality

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

explore

Food makers tried to stack nutrition panel with preferred experts

Hospitals consider fixing cancer drug shortages on their own

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

FDA panel endorses Alnylam’s heart drug — after picking it apart

New company forms to vet health AI models, root out weaknesses

focus

hotspot

leisure time

hotspot